A 3D convolutional neural network identifies candidate residues for mutation in target proteins.
Mapping RNA expression levels across sequencing protocols via reference gene transformations resolves batch effects and enables direct cohort comparison.
Full spectrum flow cytometry system generates spectral fingerprints to identify human myeloid derived suppressive cells.
Segregated convolution layers on an FPGA reduce memory access complexity while accelerating deep learning base callers.
Embedder models cluster sequences by biophysical properties to resolve detection sensitivity limits.
Imputation system identifies rare genetic variants using identity by descent segments, resolving precision constraints in large genomic databases.
Automated extraction of biological assertions from publications enables rapid knowledgebase construction.
A management device consolidates gene panel test requests and attributes into a single interface.
A neural network predicts crystal poses and induced fit using loss functions to adjust atomic coordinates.
Discrepancy guided volumetric probability diffusion preserves fine protein structures, resolving precision and reliability trade-offs in drug design.
Prediction models assess genetic markers and parent characteristics to prioritize testing, reducing time consumption while maintaining selection accuracy.
Multi-dimensional tensor processing through pooled convolutional layers resolves high indel error rates in single molecule sequencing.
A reporter transcription unit population uses processing tags to differentiate multiple cis-regulatory sequences within a single molecular framework.
A biomarker model using follistatin levels to predict type 2 diabetes risk.
Machine learning models convert phylogenetic trees into vector representations to generate nucleic acid or protein sequences.
Analyzing D- and L-amino acid levels replaces inaccurate serum creatinine markers, delivering precise kidney disease prognosis predictions.
Electronic system combines environmental data with genotypic performance metrics using RR-BLUP regression to generate yield predictions.
A machine learning classifier analyzes gene expression networks to determine variant pathogenicity.
A 3D convolutional neural network identifies candidate residues for mutation in target proteins to produce mutated variants with improved stability characteristics.